Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Liraglutide on Endothelial Function in T2DM
NCT01208012Phase 4Completed
- Sponsor
- ikfe CRO
- Start
- Apr 2010
- Primary completion
- Nov 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by ikfe CRO. Started Apr 2010; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01208012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208012.